Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Healthcare has been running neck and neck with energy and consumer discretionary for the worst sector of 2025.

Growing demand for natural weight loss solutions drives the weight management supplements market across health-conscious consumer segments.

Eli Lilly and Company (NYSE:LLY) recently announced that Australia’s Therapeutic Goods Administration (TGA) has approved Kisunla (donanemab) for marketing. The drug, administered via intravenous ...